Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04372238 · ClinicalTrials.gov registry record · NA

The Rhode Island Prescription and Illicit Drug Study

A NA study, sponsored by Brown University.

Completed
Registry status
NA
Development phase
509
Enrollment target

NCT04372238 is a NA study that has completed, run by Brown University. The registered enrollment target is 509 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04372238, a NA study, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
509 participants
Enrollment target

Study Summary

This study will test the efficacy of a novel drug-checking intervention to prevent fatal and non-fatal overdose among people who use drugs (PWUD), who are 18-65 years old at the time of enrollment. The investigators will evaluate whether the incorporation of rapid fentanyl testing into a theory-driven overdose education and prevention intervention reduces rates of overdose compared to standard overdose education and naloxone distribution. Results from this study will significantly improve public health efforts to address the fentanyl overdose epidemic and reduce harms associated with exposure to drugs contaminated with fentanyl. This is a full clinical trial, building on the previously approved fentanyl-test-strip pilot study (2016-2017), the results of which have recently been published.(Krieger et al., 2018)

Interventions

  • BEHAVIORAL RAPIDS Intervention
  • BEHAVIORAL Standard OEND

Trial Details

FieldValue
Enrollment Target 509 participants
Start Date 2020-08-31
Est. Completion 2024-02-29
Phase NA

Sponsor

Brown University

231 total trials

What the Registry Record Tells You About NCT04372238

The ClinicalTrials.gov registry entry for NCT04372238 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 509 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which RAPIDS Intervention is the first listed.

NCT04372238 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04372238 about?

NCT04372238 is a clinical study titled "The Rhode Island Prescription and Illicit Drug Study". This study will test the efficacy of a novel drug-checking intervention to prevent fatal and non-fatal overdose among people who use drugs (PWUD), who are 18-65 years old at the time of enrollment. The investigators will evaluate whether the incorporation of rapid fentanyl testing into a theory-driv...

What is the current status of trial NCT04372238?

This trial is currently completed. It is a NA study. The enrollment target is 509 participants. The study started on 2020-08-31. Estimated completion is 2024-02-29.

What interventions are being tested in trial NCT04372238?

The interventions under investigation include: RAPIDS Intervention (BEHAVIORAL), Standard OEND (BEHAVIORAL).

Who is sponsoring clinical trial NCT04372238?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.